CLINICAL TRAIL FOR PATIENTS SUFFERING FROM PSORIASIS
Are you an adult suffering from moderate to severe psoriasis? Have you been suffering for at least a year and have had no exposure to biologics for treatment? If so, you may be eligible to participate in our study.
SIU School of Medicine is participating in a clinical trial, sponsored by Celgene Corporation, to test the investigational drug Apremilast in the treatment of psoriasis, and compare its effects to a placebo. The study will also test Etanercept, a drug approved to treat psoriasis, and compare its effects to placebo.
If you are chosen to participate, you will have a physical examination, physician assessments, and you will be asked to complete questionnaires. Urine and blood samples will also be taken. You will receive a weekly injection and a pill to be taken twice a day for the first 16 weeks of the study. During this time, you may receive a placebo pill, a placebo injection, or both. After that, you will only receive a pill (active medication) to be taken during the rest of the study. The study is scheduled to last for approximately 2 years.
Please contact Lori Miedwig, CCRP, at (217) 545-4402 or email email@example.com for more information and to see if you qualify.